TP53 and non-small cell lung carcinoma: The most recent studies have revealed that the suppression of the p53 signaling pathway could accelerate tumor progression in lung cancer (Hao et al., 2018) and that the cell cycle pathway is involved in leptomeningeal metastasis of NSCLC (Fan et al., 2018).